GE HealthCare Changes Reportable Segments, Creates Advanced Imaging Solutions

What Happened
GE HealthCare Technologies Inc. filed a Form 8-K on July 29, 2026 to disclose a strategic change made in the second quarter of 2026: the company combined its Imaging and Advanced Visualization Solutions (AVS) businesses into a single new reportable segment called Advanced Imaging Solutions (AIS). The change aligns reporting with how the Chief Operating Decision Maker reviews the business and the company now has three reportable segments: Advanced Imaging Solutions (AIS), Pharmaceutical Diagnostics (PDx), and Patient Care Solutions (PCS). The filing includes recast unaudited historical financial information to reflect the new segment structure; the recast is intended for comparability and does not change previously reported consolidated financial statements.

Key Details

• Change announced in Q2 2026; Form 8‑K filed July 29, 2026 and signed by George A. Newcomb, Controller & Chief Accounting Officer.
• New reportable segments: AIS (combines former Imaging and AVS), PDx, and PCS; no operating segments were aggregated.
• AIS product areas include Radiology (CT, MR, MI, X‑ray, women’s health, enterprise imaging), Specialized Ultrasound, and Procedural Guidance (cardiovascular/interventional, surgical imaging).
• Exhibit 99 attached to the 8‑K provides recast unaudited historical financial information reflecting the new segment presentation.

Why It Matters
For investors, the reorganization changes how GE HealthCare reports and tracks segment-level revenue, margins, and performance metrics — affecting trend comparisons and analyst models that split the business by prior segments. Because the company provided recast financials, historical segment results will be comparable under the new structure, but investors should review Exhibit 99 and future earnings releases for updated segment revenue and profitability trends. The filing states the recast does not alter consolidated reported financial statements.